A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT06128564 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06128564
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-29
- Primary completion
- 2026-03-04
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.